Subjective expectations regarding length and health‐related quality of life in Hungary: results from an empirical investigation

Abstract

Background Subjective expectations regarding future health are rarely studied, yet may have implications for medical decision making, health behaviour and health economic analysis.

Moderate to severe psoriasis patients' subjective future expectations regarding health‐related quality of life and longevity

“…Péntek et al . observed an overestimation of subjective LE compared to statistical LE in a large, although non‐representative sample of the general public in Hungary . Compared to those results, psoriasis patients' estimates lag behind in both genders that might reflect some disease‐related concerns.…”

“…Patients were asked not to respond to questions about future life years that they had already reached, and answers of those who responded despite of passing a certain age were excluded. This methodology was previously used in the Netherlands and as well in Hungary in large expectation surveys on the general population, and also in a recent study with Hungarian RA patients …”

Rational expectations? An explorative study of subjective survival probabilities and lifestyle across Europe

“…These considerations also raise the question whether it is more informative to analyse all country samples separately instead of aggregating these subsamples to one sample. In that context, a recent cross‐sectional study, Péntek et al . found that subjective life expectancy patterns (using a point estimate) in Hungary and the Netherlands were similar, despite differences in actuarial life expectancy and cultural diversity.…”

Real-life experience with switching TNF-α inhibitors in ankylosing spondylitis

“…The precision and applicability of these data to other settings may be argued. In the real world of prescription and use, drugs are applied in a broader population, use of concomittant medicines may vary, the same as patients' compliance and their expectations for health (17). Moreover, biological drug sequences that do indeed occur in everyday practice (e.g., switch to a third or fourth drug, return back to a previous one) have never been studied in RCTs.…”